Xiaojie Feng Selected Research

soyasapogenol B

3/2021	Retraction Note to: Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma.
1/2019	Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaojie Feng Research Topics

Disease

5	Neoplasms (Cancer) 11/2021 - 11/2019
3	Uveitis 01/2022 - 01/2022
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 09/2019
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
2	Infections 01/2022 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2021 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 06/2019 - 01/2019
2	Osteoporosis 11/2018 - 01/2012
1	Growth Disorders 04/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Hepatitis 01/2022
1	Hepatitis B 01/2022
1	Tuberculosis (Tuberculoses) 04/2021
1	Behcet Syndrome (Behcet's Syndrome) 04/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Ankylosing Spondylitis 01/2021
1	Kidney Calculi (Kidney Stone) 12/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Ovarian Epithelial Carcinoma 01/2019
1	Lymphocele 10/2015
1	Lymphedema (Milroy Disease) 10/2015
1	Hemorrhage 10/2015
1	Wounds and Injuries (Trauma) 10/2015
1	Cellulitis 10/2015
1	Pleomorphic Adenoma 05/2012

Drug/Important Bio-Agent (IBA)

2	ChromatinIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 11/2021 - 01/2021
2	soyasapogenol BIBA 03/2021 - 01/2019
2	Diphosphonates (Bisphosphonates)IBA 11/2018 - 01/2012
1	SugarsIBA 04/2022
1	CarbonIBA 04/2022
1	LuciferasesIBA 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Ranibizumab (Lucentis)FDA Link 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	HLA-A*26 antigenIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	CopperIBA 12/2021
1	OxidesIBA 12/2021
1	Selenoproteins (Selenoprotein)IBA 11/2021
1	SeleniumIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Oxidoreductases (Dehydrogenase)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Coenzyme A (CoA)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	ORALIT (ORS)IBA 12/2020
1	matrigelIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	Cyclin EIBA 05/2012
1	Zoledronic Acid (Zometa)FDA Link 01/2012
1	AcidsIBA 01/2012
1	Dental Implants (Dental Implant)IBA 01/2012

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2019
3	Radiotherapy 01/2021 - 09/2019
2	Adjuvant Chemotherapy 01/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 11/2019
1	Transjugular Intrahepatic Portasystemic Shunt 04/2022
1	Adjuvant Radiotherapy 01/2021
1	Neoadjuvant Therapy 01/2020
1	Operative Time 10/2015